Objective: Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of (18)F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including (124)I, (18)F-dihydroxyphenylalanine, and (68)Ga somatostatin analogs, is summarized.
Conclusion: PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2214/AJR.13.11673 | DOI Listing |
Publication Analysis
Top Keywords
thyroid cancers
12
management thyroid
8
thyroid
5
pet/ct management
4
cancers objective
4
objective thyroid
4
thyroid cancer
4
cancer common
4
common endocrine
4
endocrine cancer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!